COVID-19 Reinfection Threat: South African Strain Resistant to Antibodies Pose Potential Risk
The new coronavirus strain discovered in South Africa is causing concern due to its potential to reinfect people, according to multiple reports.
According to REN TV and Almaty.tv, about half of those who have recovered from the virus could be reinfected by the South African strain. The risk of reinfection is significant, even for those who have presumably built up some level of immunity, as stated by RIA "Novosti".
The risk assessment is based on data from the Medical Xpress portal, as reported by RIA "Novosti". The new strain, known as strain 501Y.V2, is resistant to antibodies built up after vaccination or previous illness. This means that previous infection or vaccination may not provide full protection against the South African strain.
The strain's ability to bypass the immune system could contribute to its potential for reinfection. The South African strain poses a significant risk of reinfection, as reported by RIA "Novosti".
The search results do not provide the name of the research group that published the study about the new coronavirus strain in South Africa with significant reinfection risk and antibody resistance.
Meanwhile, the US predicts half a million COVID-19 deaths by mid-February. The ongoing pandemic continues to pose a significant threat worldwide, underscoring the importance of adhering to public health guidelines and getting vaccinated when eligible.
Read also:
- Nightly sweat episodes linked to GERD: Crucial insights explained
- Antitussives: List of Examples, Functions, Adverse Reactions, and Additional Details
- Asthma Diagnosis: Exploring FeNO Tests and Related Treatments
- Unfortunate Financial Disarray for a Family from California After an Expensive Emergency Room Visit with Their Burned Infant
